JUNS
Jupiter Neurosciences, Inc.NASDAQHealthcare$0.34-7.51%ClosedMarket Cap: $11.7M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
-6.23
P/S
0.00
EV/EBITDA
0.00
DCF Value
$-0.05
FCF Yield
-46.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
ROA
0.0%
ROIC
0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $0.00 | NaN% | $0.00 | $0.00 | $0.00 | — |
| Q3 2025 | $0.00 | NaN% | $-2.3M | $-2.3M | $-0.07 | — |
| Q2 2025 | $0.00 | NaN% | $-2.3M | $-2.3M | $-0.07 | — |
| Q1 2025 | $0.00 | NaN% | $-1.5M | $-1.5M | $-0.05 | — |
| Q4 2024 | $0.00 | NaN% | $-1.5M | $-1.5M | $-0.05 | — |
| FY 2024 | $0.00 | NaN% | $-3.1M | $-2.4M | $-0.08 | — |
| Q3 2024 | $0.00 | NaN% | $-493.5K | $-591.0K | $-0.02 | — |
| Q2 2024 | $0.00 | NaN% | $-557.1K | $313.1K | $0.01 | — |
| Q1 2024 | $0.00 | NaN% | $-570.7K | $-634.1K | $-0.02 | — |
| Q4 2023 | $0.00 | NaN% | $-535.6K | $-429.6K | $-0.01 | — |
| FY 2023 | $0.00 | NaN% | $-3.9M | $-4.8M | $-0.14 | — |
| Q3 2023 | $0.00 | NaN% | $-1.4M | $-1.8M | $-0.07 | — |